SHIVANI SHARMA: Open Payments
NPI 1215342902 · NORTH CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 54 payments from 12 companies in 2025. Trend: 2023 $114 · 2024 $24 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $340 |
| Otsuka America Pharmaceutical, Inc. | 12 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
| TMS NeuroHealth Centers Inc. | 2 | $62 |
| Bausch Health US, LLC | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Lundbeck LLC | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 1 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
| Axsome Therapeutics, Inc. | 2 | $32 |
Products named: REXULTI, VRAYLAR, CAPLYTA, TMS NeuroHealth Centers Inc., APLENZIN, SPRAVATO, Qelbree, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
